Clin2
NCT06651541Possibly a fitNot yet recruiting

Study of BZ371A for women with sexual arousal problems

Female Sexual Arousal DisorderFemale Sexual Dysfunction (FSD)

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests a medication (BZ371A) that may help women with sexual arousal disorder—a condition where the body doesn't respond physically (like lubrication or swelling) despite feeling interested. The trial aims to see if this medication can increase sexual arousal, and checks safety and side effects over a period of time with your partner.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
174 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You are a woman between 21 and 65 years old.
  • You have had satisfying sexual experiences (with orgasm, desire, and arousal) for at least 2 years in the past.
  • You currently have trouble getting or keeping the physical signs of arousal (like lubrication or swelling), and it bothers you or affects your relationship.
  • You are in a stable relationship (more than 6 months) with a partner who will be available during the study.
  • You do not have untreated depression, diabetes, heart problems, or a history of certain surgeries or cancers.
  • You are willing to try sexual activity at least twice a week while using the study medication.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06116045Recruiting· Phase 2
Study of BZ371A for women with sexual arousal disorder

This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.

Rio de Janeiro, Rio de Janeiro
NCT06516055Not yet recruiting· Phase 2
Study of an experimental drug for women with orgasm difficulty

This study tests an experimental medication (S1B-408) to see if it helps women who have trouble reaching orgasm. The trial will check if the drug improves orgasm function compared to a placebo, and you will need to have a willing partner and be sexually active.

NCT07606664Not yet recruiting· Phase 3
Study of a hot flash medication and its effects on heart and brain health

This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.

Chicago, Illinois
NCT06932302Recruiting
At-home electrical stimulation for female sexual function

This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.

Ann Arbor, Michigan
NCT06197568Recruiting· Phase 2
Study of AZU-101 cream for vaginal dryness in menopause

This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.

Saint Paul, Minnesota
NCT07408440Not yet recruiting
Testosterone gel for low sexual desire in women around or after menopause

This trial tests a testosterone gel (applied to the skin) to see if it helps women with low sexual desire or arousal around and after menopause. It may help by increasing your sexual interest and improving your response to sexual activity.

Houston, Texas

Hear when a new Female Sexual Arousal Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.